Ole Jannik Bjerrum

Ole Jannik Bjerrum

Professor emeritus


  1. Udgivet

    Analysis of the Authorized Target Populations for Fixed Dose Combination Products Between 2000 and 2017 Reveals Discrepancies Between EMA's and FDA's Views on Initial Dual-Therapy

    Bjerrum, Ole Jannik, Eichendorff, S. & Alkis, N. B., mar. 2020, I: Therapeutic Innovation & Regulatory Science. 54, 2, s. 297-302 6 s.

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

  2. Udgivet

    Demonstrating Contribution of Components of Fixed-Dose Drug Combinations Through Longitudinal Exposure-Response Analysis

    Nøhr-Nielsen, A., Lange, Theis, Forman, Julie Lyng, Papathanasiou, T., Foster, D. J. R., Upton, R. N., Bjerrum, Ole Jannik & Lund, Trine Meldgaard, 2020, I: The AAPS Journal. 22, 2, 32.

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

  3. Udgivet

    Pregabalin alleviates clinical signs of syringomyelia-related central neuropathic pain in Cavalier King Charles Spaniel dogs: a randomized controlled trial

    Thoefner, M. S., Skovgaard, Lene Theil, McEvoy, Fintan, Berendt, Mette & Bjerrum, Ole Jannik, 2020, I: Veterinary Anaesthesia and Analgesia. 47, 2, s. 238–248

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

ID: 1302721